Law Jia Xian, Chowdhury Shiplu Roy, Saim Aminuddin Bin, Idrus Ruszymah Bt Hj
Tissue Engineering Centre, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, 56000, Kuala Lumpur, Malaysia.
Ear, Nose & Throat Consultant Clinic, Ampang Puteri Specialist Hospital, 68000, Ampang, Selangor, Malaysia.
J Tissue Viability. 2017 Aug;26(3):208-215. doi: 10.1016/j.jtv.2017.05.003. Epub 2017 Jun 7.
Advances in tissue engineering led to the development of various tissue-engineered skin substitutes (TESS) for the treatment of skin injuries. The majority of the autologous TESS required lengthy and costly cell expansion process to fabricate. In this study, we determine the possibility of using a low density of human skin cells suspended in platelet-rich plasma (PRP)-enriched medium to promote the healing of full-thickness skin wounds. To achieve this, full-thickness wounds of size 1.767 cm were created at the dorsum part of nude mice and treated with keratinocytes (2 × 10 cells/cm) and fibroblasts (3 × 10 cells/cm) suspended in 10% PRP-enriched medium. Wound examination was conducted weekly and the animals were euthanized after 2 weeks. Gross examination showed that re-epithelialization was fastest in the PRP+cells group at both day 7 and 14, followed by the PRP group and NT group receiving no treatment. Only the PRP+cells group achieved complete wound closure by 2 weeks. Epidermal layer was presence in the central region of the wound of the PRP+cells and PRP groups but absence in the NT group. Comparison between the PRP+cells and PRP groups showed that the PRP+cells-treated wound was more mature as indicated by the presence of thinner epidermis with single cell layer thick basal keratinocytes and less cellular dermis. In summary, the combination of low cell density and diluted PRP creates a synergistic effect which expedites the healing of full-thickness wounds. This combination has the potential to be developed as a rapid wound therapy via the direct application of freshly harvested skin cells in diluted PRP.
组织工程学的进展促使各种组织工程皮肤替代物(TESS)得以开发,用于治疗皮肤损伤。大多数自体TESS的制造需要漫长且昂贵的细胞扩增过程。在本研究中,我们确定了使用低密度悬浮于富含血小板血浆(PRP)的培养基中的人皮肤细胞来促进全层皮肤伤口愈合的可能性。为此,在裸鼠背部制造1.767平方厘米的全层伤口,并用悬浮于10%富含PRP的培养基中的角质形成细胞(2×10个细胞/平方厘米)和成纤维细胞(3×10个细胞/平方厘米)进行处理。每周进行伤口检查,并在2周后对动物实施安乐死。大体检查显示,在第7天和第14天,PRP + 细胞组的再上皮化最快,其次是PRP组和未接受治疗的NT组。只有PRP + 细胞组在2周时实现了完全伤口闭合。PRP + 细胞组和PRP组伤口中央区域存在表皮层,而NT组则没有。PRP + 细胞组与PRP组之间的比较表明,PRP + 细胞处理的伤口更成熟,表现为表皮更薄,基底角质形成细胞为单细胞层厚度,真皮细胞较少。总之,低细胞密度和稀释的PRP相结合产生了协同效应,加速了全层伤口的愈合。这种组合有潜力通过将新鲜采集的皮肤细胞直接应用于稀释的PRP中,开发成为一种快速伤口治疗方法。